PPT-WATCHMAN™ Left Atrial Appendage Closure Device

Author : alexa-scheidler | Published Date : 2015-10-19

wwwwatchmandevicecom AF is a Growing Problem Associated with Greater Morbidity and Mortality 5 M people with AF in US expected to more than double by 2050 1

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "WATCHMAN™ Left Atrial Appendage Closur..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

WATCHMAN™ Left Atrial Appendage Closure Device: Transcript

wwwwatchmandevicecom AF is a Growing Problem Associated with Greater Morbidity and Mortality 5 M people with AF in US expected to more than double by 2050 1 AF most common cardiac . The LAA is a normal part of the heart anatomy and causes no problems in the general population However this pouch is a major source of blood clots in patients with atrial fibrillation Atrial fibrillation AF is the biggest risk factor for blood clots The following information about the WATCHMAN implant is important for you to know along with medication recommendations and common questions you may have about your implant UNDERSTANDING YOUR HEART This section will discuss the basic function of th versus Warfarin Therapy for Prevention of Stroke . in Patients with Atrial Fibrillation: A Randomized . Non-Inferiority Trial. David R. Holmes, MD. Vivek Y. Reddy, MD. Zoltan G. Turi, MD. Shephal K. Doshi, MD. Mike Clark, M.D.. Figure 18.23. (a) Day 20:. . Endothelial. . tubes begin. . to fuse.. (b) Day 22:. . Heart. . starts. . pumping.. . (c) Day 24: . Heart. . Meta-Analysis and Implications . David R. Holmes, Jr., M.D.. Mayo Clinic, Rochester . TCT 2014. Washington, D.C.. September 2014. Presenter Disclosure Information. David R. Holmes, Jr., M.D.. “. Watchman II: PROTECT AF/PREVAIL. Percutaneous. Left Atrial Appendage (LAA) Exclusion. Aaditya Vora, MD. Cardiac Electrophysiologist. Baptist heart specialists. Disclosures. None. > . 33M. people with . AF Worldwide. 1. Many patients are unprotected. Vivek Y. Reddy MD. 1. *, Douglas N. Gibson MD. 2. , . Saibal. Kar. 3. , William O’Neill MD. 4. , . Shephal. K. . Doshi. MD. 5. , Rodney P. Horton MD. 6. , Maurice . Buchbinder. MD. 7. , Nicole T. Gordon BSEE. Meta-Analysis and Implications . David R. Holmes, Jr., M.D.. Mayo Clinic, Rochester . TCT 2014. Washington, D.C.. September 2014. Presenter Disclosure Information. David R. Holmes, Jr., M.D.. “. Watchman II: PROTECT AF/PREVAIL. Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. . Product Overview . MKT-2387A-G. LAA Management Guidelines. MKT-2387A-G. Society. Recommendation. STS (2017). “It is REASONABLE to perform left atrial appendage excision or exclusion in conjunction with surgical ablation for AF for longitudinal thromboembolic morbidity prevention. (Class IIA, Level C limited data)” . The Randomized MITHRAS Trial. . Philipp . Lurz. , Matthias . Unterhuber. , Karl-Philipp Rommel, Karl-. Patrik. . Kresoja. , . Tobias . Kister. , Christian Besler, Karl . Fengler. , Marcus Sandri, Ingo . CARDIAC INTERVENTIONS TODAY 29 A trial septal defect (ASD) is the second most com - mon congenital cardiac anomaly. In this article, we review the physiology of ASD, as well as the indications and m A retrospective study of atrial septal defect . IAIM, 2016; 3(10 ): 7 - 16. Page 7 Original Research Article A retrospective study of atrial septal defect G Ravindra 1* , Abhijeet M Dashetwar 1 1 As Seminar Atrial septal defectsTal Geva, Jose D Martins, Rachel M WaldAtrial septal defects are the third most common type of congenital heart disease. Included in this group of pulmonary circulations.

Download Document

Here is the link to download the presentation.
"WATCHMAN™ Left Atrial Appendage Closure Device"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.